Jing Tang1, Kai Ai2, Jie Li1, Fang Li1, Mingfang Luo1, Bo He1, Xiaoyong Zhang3, and Yuting Wang1
1Sichuan Provincial people’s hospital, Chengdu, China, 2Department of clinical and technical support, Philips Healthcare, Xi’an, China, 3Department of clinical and technical support, Philips Healthcare, Chengdu, China
Synopsis
Keywords: Neuro, Metabolism
Motivation: It is unclear whether the lack of growth hormone (GH) is accompanied by altered GABA in human brain and relationship between the alterations and neuronal activity.
Goal(s): Thalamus is one of brain region that has highest concentration of GH receptors. The purpose of this study was to explore changes in GABA concentrations in thalamus and its association with neuronal activity in children with GHD.
Approach: We used MEGA-PRESS sequence to quantify the concentration of GABA+ in thalamus and rs-fMRI to assess neuronal activity.
Results: We found that the levels of thalamus GABA+ decreased significantly, and it was related to abnormal neuronal activity.
Impact: This study provides a new insight into
the neural mechanisms of cognitive dysfunction in children with GHD, and holds a promising biomarker for us to find a new
treatment approach to GHD.
Introduction
Growth hormone (GH) plays a
pivotal role in proper development and functioning of the human brain,
with thalamus being one of the brain regions that
boasts the highest concentration of GH receptors[1-3].
GH deficiency (GHD) is a recognized endocrine abnormality, with an incidence
rate as high as 1/4000 in children, which present as defects of linear growth
and is more likely to have cognitive deficits[3-6]. Gamma-aminobutyric
acid (GABA) is one of major inhibitory neurotransmitter in human brain. It
plays a crucial regulatory role in brain function and involved in the
regulation of GH[7, 8]. Therefore,
it is important to understand whether the lack of GH in children is associated
with changes in GABA levels in brain and to explore the relationship between
the alterations and the brain activity.
This study aims to explore the changes in
GABA concentrations in thalamus, and its association with neuronal activity in
children with GHD by using magnetic resonance spectroscopy (MRS) and
resting-state functional MRI (rs-fMRI)
methods.Materials and Methods
In this study, 7 children
with GHD and 8 children with idiopathic short stature (ISS, GH not
deficiency) were recruited. Data were collected using
a 3.0 T MR scanner (lngenia Elition, Philips Healthcare, the Netherlands) with a 32-channel head coil. The MRS data
was acquired by MEscher-GarwOod point resolved spectroscopy (MEGA-PRESS) sequence. For each participant, a 30 × 20 × 20 mm3
volume of interest (VOI) was placed at thalamus. The parameters of the
MEGA-PRESS were as follows: TR/TE = 2000/68 ms, Gaussian
editing pulses at 1.89 parts per million (ppm) of the proton frequency (edit-ON) and 7.46 ppm (edit-OFF), 288 averages,
1024 acquisition points and scanning duration = 612 seconds. Variable power and
optimized relaxation delays was used for water suppression. MRS data were
analyzed using Gannet 3.0 (http://www.gabamrs.com/)[9]. The measured GABA concentration using MEGA-PRESS
protocol commonly referred to as GABA+ with the contribution from
macromolecules. The contents of GABA+ and Glx (glutamate and glutamine) in gray
matter were evaluated with spm12 toolbox.
The BOLD date was acquired by SE-EPI
sequence with the parameters as: TR/TE = 2000/35 ms, 220 time points,
spatial resolution = 3 x 3 x 4 mm3 and scanning duration = 440 seconds. The static amplitude of low-frequency fluctuation
(sALFF) and dynamic ALFF (dALFF) metrics were performed to explore the
alteration of brain activity. Rs-fMRI data was processed using DPABI toolbox (https://www.rfmri.org/DPABI). Statistical analysis was performed by SPSS v25.0. The comparison of group
differences was performed by using independent sample t-test. Voxel-wise two-sample t-tests were implemented within the
thalamus mask to assess differences in sALFF and dALFF between two group
using DPABI toolbox. Results
The demographic data were
shown in Table 1. VOl of
MRS was placed at thalamus (Figure 1A). A typical GABA+ / Glx spectra obtained from thalamus
were shown in Figure 1B. Compared with ISS group, the GABA+ concentration in thalamus
significantly decreased in GHD group (Table 1). Similarly,
GHD group showed decreased sALFF and dALFF in the left thalamus (Table 2 and Figure 2) compared
with ISS
group. The results of correlation analysis were shown in Figure 3. The
concentration of GABA+ was positively
correlated with IGF-1 (r = 0.767, p = 0.044),
sALFF (r = 0.769, p = 0.043) and dALFF (r = 0.805, p = 0.029) in GHD group. Meanwhile,
the abnormal IGF-1 was significantly positively correlated with sALFF (r = 0.758,
p = 0.048) and dALFF (r = 0.822, p = 0.023). Discussion
In this study, we
investigated the neurochemical transmitters (GABA+ and Glx), neuronal activity
of thalamus (sALFF and dALFF) and their relationship with clinical indices (IGF-1) in children with GHD. The main results were
as follows: First, the GABA+ levels of thalamus in GHD group decreased significantly,
and it was related to abnormal sALFF, dALFF and IGF-1. The decrease of IGF-1 is
related to the severity of GHD[10]. Thus, these
results suggest that the lack of GH in children is
accompanied by altered GABA in thalamus, and dysfunction in thalamus is related
to the imbalance of GABA+. Secondly, the IGF-1 was related to abnormal sALFF
and dALFF in GHD group, indicating that GH may directly influence the thalamic
function besides the alteration of GABA+.Conclusion
This study revealed a decrease trend in
GABA+ levels in thalamus associated with thalamic activity in children with GHD.
These results provide a new insight into the neural mechanisms of cognitive
dysfunction in children with GHD, and holds a promising
biomarker for us to find a new treatment approach to GHD.Acknowledgements
We are grateful to
all the participants for their cooperation.References
1. SONNTAG W E,
RAMSEY M, CARTER C S. Growth hormone and insulin-like growth factor-1
(IGF-1) and their influence on cognitive aging [J]. Ageing Res Rev,
2005, 4(2): 195-212.
2. YUAN T, YING J,
JIN L, et al. The role of serum growth hormone and insulin-like growth factor-
1 in adult human brain morphology [J]. Aging, 2020, 12(2): 1377-96.
3. WEBB E A,
O'REILLY M A, CLAYDEN J D, et al. Effect of growth hormone deficiency on brain
structure, motor function and cognition [J]. Brain, 2012, 135(1):
216-27.
4. SAVAGE M, STORR
H, BACKELJAUW P. The continuum between GH deficiency and GH
insensitivity in children [J]. Rev Endocr Metab Disord, 2021, 22(1):
91-9.
5. MURRAY P,
DATTANI M, CLAYTON P. Controversies in the diagnosis and management of
growth hormone deficiency in childhood and adolescence [J]. Arch Dis
Child, 2016, 101(1): 96-100.
6. HU Y, LIU X,
CHEN X, et al. Differences in the functional connectivity density of the brain
between individuals with growth hormone deficiency and idiopathic
short stature [J].
Psychoneuroendocrinology, 2019,
103: 67-75.
7. POWERS M J M,
SCIENCE S. GABA supplementation and growth hormone response [J]. 2012,
59: 36-46.
8. DUMAN R,
SANACORA G, KRYSTAL J J N. Altered Connectivity in Depression: GABA and
Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
[J]. 2019, 102(1): 75-90.
9. EDDEN R, PUTS N,
HARRIS A, et al. Gannet: A batch-processing tool for the quantitative analysis of
gamma-aminobutyric acid–edited MR spectroscopy spectra [J]. 2014, 40(6):
1445-52.
10. AGUIAR-OLIVEIRA M,
GILL M, DE A BARRETTO E, et al. Effect of severe growth hormone (GH)
deficiency due to a mutation in the GH-releasing hormone receptor on
insulin-like growth factors
(IGFs), IGF-binding proteins, and ternary complex formation
throughout life [J]. J Clin Endocrinol
Metab, 1999, 84(11): 4118-26.